Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Number of items: 6.

Browne, Brigid C., Hochgräfe, Falko, Wu, Jianmin, Millar, Ewan K. A., Barraclough, Jane, Stone, Andrew, McCloy, Rachael A., Lee, Christine S., Roberts, Caroline, Ali, Naveid A., Boulghourjian, Alice, Schmich, Fabian, Linding, Rune, Farrow, Lynne, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Nicholson, Robert Ian, O'Toole, Sandra A., Sutherland, Robert L., Musgrove, Elizabeth A., Butt, Alison J. and Daly, Roger J. 2013. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. FEBS Journal 280 (21) , pp. 5237-5257. 10.1111/febs.12441

Stone, Andrew, Valdés-Mora, F., Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Farrow, Lynne, McClelland, Richard Andrew, Fiegl, H., Dutkowski, Carol Mary, McCloy, R. A., Sutherland, R. L., Musgrove, E. A. and Nicholson, Robert Ian 2012. Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer. PLoS ONE 7 (7) , e40466. 10.1371/journal.pone.0040466
file

Nicholson, Robert Ian, Habashy, H., Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Finlay, Pauline, Farrow, Lynne, Jasani, Bharat, Barrett-Lee, Peter, Robertson, J. and Ellis, Ieuan ORCID: https://orcid.org/0000-0001-6231-5217 2011. Abstract P2-06-19: Transferrin Receptor (CD71) identifies poor response to Tamoxifen in oestrogen receptor positive breast cancer patients [Abstract]. Cancer Research 70 (24 Sup) , P2-P6. 10.1158/0008-5472.SABCS10-P2-06-19

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Aleskandarany, M., Finlay, Pauline, Farrow, Lynne, Nicholson, Robert Ian, Habashy, H., Green, Adam, Rakha, E., Powell, D., Jasani, Bharat, Barrett-Lee, Peter, Robertson, J., Shaw, Victoria E. and Ellis, Ieuan ORCID: https://orcid.org/0000-0001-6231-5217 2011. Abstract P2-09-37: Immunohistochemical markers progesterone receptor, HER2, Ki67 and bcl-2-Associated Athanogene 1 and prediction of adjuvant Tamoxifen treatment outcome in ER+ early breast cancer [Abstract]. Cancer Research 70 (24 Sup) , P2-09. 10.1158/0008-5472.SABCS10-P2-09-37

Morgan, Liam David ORCID: https://orcid.org/0000-0002-7571-6025, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Pumford, Sara Louise, Farrow, Lynne, Finlay, Pauline, Robertson, John, Ellis, Ian, Kawakatsu, Hisaaki, Nicholson, Robert Ian and Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702 2009. Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically. Cancer Biology and Therapy 8 (16) , pp. 1550-1558. 10.4161/cbt.8.16.8954

Knowlden, Janice Mary, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Seery, L. T., Farrow, Lynne, Gullick, W. J., Ellis, I. O., Blamey, R. W., Robertson, J. F. R. and Nicholson, Robert Ian 1998. C-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene 17 (15) , pp. 1949-1957.

This list was generated on Thu Mar 28 10:25:14 2024 GMT.